PATENT CLAIM ANALYSIS

Application Number: 15765357
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "001300"]

Abstract:
The invention described herein provides novel ampiphilic compounds that self-assemble into a hydrogel composition useful for treating wounds, including chronic wounds and diabetic wounds. The compounds of the invention have structural characteristics, such as hydrophilic and hydrophobic moieties, that enable self-assembly into discrete nanostructures, which then entangle to form the hydrogel. Also provided are methods for treating wounds.

Claim (Index 2):
The compound of  claim 1 , wherein the peptide fragment is covalently linked to the residue of the drug molecule through one or more covalent bonds, wherein at least one bond is selected from amide, carbonate, carbamate, ester, ether, disulfide, sulfonate, and sulfamate.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 91.0
- Lexical Diversity: 1.38298
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15525435', '15054739', '11978122', '11244402', '15201301']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7426772648854856
- 35 USC 102 Novelty (BERT): 0.4826477825128174
- Combined Prediction Score: 0.7166743166482188
- Mean Citation Score: 156.44300600000005
- Max Citation Score: 206.46445
- Similarity Product: 162.6652366631925

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test